Characterization of the interaction of a TCR α chain variable domain with MHC II I-A molecules

International Immunology

Volumn 11, Issue 6, 1999, Pages 967-977

  Qadri, Ayub ^a,b   Thatte, Jayant ^a,c   Radu, Caius G ^a   Ober, Bertram ^a,d   Ward, E Sally ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Fourth hypervariable region; Immunosuppression; MHC class II; TCR; V( ) domain

Indexed keywords

ALANINE; EPITOPE; GLUTAMIC ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CELL LINE; CELL POPULATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HAPLOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; THYMOMA;

AMINO ACID SUBSTITUTION; ANIMALS; B-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TUMOR CELLS, CULTURED;

EID: 0033033582     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/11.6.967     Document Type: Article

References (70)

1. Fields, B. A. and Mariuzza, R. A. 1996. Structure and function of the T-cell receptor: insights from X-ray crystallography. Immunol. Today 17:330.
2. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
3. York, I. A. and Rock, K. L. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
4. Alzari, P. M., Lascombe, M. B. and Poljak, R. J. 1988. Three-dimensional structure of antibodies. Annu. Rev. Immunol. 6:555.
5. Davies, D. R., Padlan, E. A. and Sheriff, S. 1990. Antibody-antigen complexes. Annu. Rev. Biochem. 59:439.
6. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L. and Wiley, D. C. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506.
7. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
8. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
9. Fremont, D. H., Hendrickson, W. A., Marrack, P. and Kappler, J. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
10. Smith, K. J., Reid, S. W., Stuart, D. I., McMichael, A. J., Jones, E. Y. and Bell, J. I. 1996. An altered position of the α 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4:203.
11. k in complex with a dominant epitope of lysozyme. Immunity 8:305.
12. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8:319.
13. α domain of a T cell antigen receptor. Science 270:1821.
14. Bentley, G. A., Boulot, G., Karjalainen, K. and Mariuzza, R. A. 1995. Crystal structure of the β chain of a T cell antigen receptor. Science 267:1984.
15. Fields, B. A., Malchiodi, E. L., Li, H., Ysern, X., Stauffacher, C. V., Schlievert, P. M., Karjalainen, K. and Mariuzza, R. A. 1996. Crystal structure of a T-cell receptor β-chain complexed with a superantigen. Nature 384:188.
16. Garcia, K. C., Degano, M., Stanfield, R. L., Brunmark, A., Jackson, M. R., Peterson, P. A., Teyton, L. and Wilson, I. A. 1996. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209.
17. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
18. Ding, Y. H., Smith, K. J., Garboczi, D. N., Utz, U., Biddison, W. E. and Wiley, D. C. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403.
19. Garcia, K. C., Degano, M., Pease, L. R., Huang, M., Peterson, P. A., Teyton, L. and Wilson, I. A. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166.
20. Wang, J., Lim, K., Smolyar, A., Teng, M., Liu, J., Tse, A. G., Hussey, R. E., Chishti, Y., Thomson, C. T., Sweet, R. M., Nathenson, S. G., Chang, H. C., Sacchettini, J. C. and Reinherz, E. L. 1998. Atomic structure of an αβ T cell receptor (TCR) heterodimer in complex with an anti-TCR Fab fragment derived from a mitogenic antibody. EMBO J. 17:10.
21. β domain. EMBO J. 16:4205.
22. α CDR1 and CDR2. Science 273:963.
23. Sant'Angelo, D. B., Waterbury, G., Preston-Hurlburt, P., Yoon, S. T., Medzhitov, R., Hong, S. C. and Janeway, C. A. J. 1996. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity. 4:367.
24. Hong, S. C., Sant'Angelo, D. B., Dittel, B. N., Medzhitov, R., Yoon, S. T., Waterbury, P. G. and Janeway, C. A. J. 1997. The orientation of a T cell receptor to its MHC class II:peptide ligands. J. Immunol. 159:4395.
25. Wraith, D. C., Smilek, D. E., Mitchell, D. J., Steinman, L. and McDevitt, H. O. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59:247.
26. Kuchroo, V. K., Byrne, M. C., Atsumi, Y., Greenfield, E., Connolly, J. B., Whitters, M. J., O'Hara, R. M. J., Collins, M. and Dorf, M. E. 1991. T-cell receptor alpha chain plays a critical role in antigen-specific suppressor cell function. Proc. Natl Acad. Sci. USA 88:8700.
27. O'Hara, R. M. J., Byrne, M. C., Kuchroo, V. K., Nagelin, A., Whitters, M. J., Jayaraman, S., Henderson, S. L., Dorf, M. E. and Collins, M. 1995. T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction. J. Immunol. 154:2075.
28. Ishii, Y., Nakano, T. and Ishizaka, K. 1996. Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells. Proc. Natl Acad Sci. USA 93:7207.
29. Pinet, V., Malnati, M. S. and Long, E. O. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852.
30. Pinet, V., Vergelli, M., Martin, R., Bakke, O. and Long, E. O. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375:603.
31. Wraith, D. C., Smilek, D. E. and Webb, S. 1992. MHC-binding peptides for immunotherapy of experimental autoimmune disease. J. Autoimmun. 5 (Suppl. A):103.
32. k form and dissociate rapidly at neutral pH. J. Immunol. 154:5216.
33. u. Biochemistry 34:14874.
34. Letourneur, F. and Malissen, B. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin. Eur. J. Immunol. 19:2269.
35. Patten, P. A., Rock, E. P., Sonoda, T., Fazekas de St Groth, B., Jorgensen, J. L. and Davis, M. M. 1993. Transfer of putative complementarity-determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J. Immunol. 150:2281.
36. α domain. J. Exp. Med. 189:509.
37. Staerz, U. D., Rammensee, H. G., Benedetto, J. D. and Bevan, M. J. 1985. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134:3994.
38. Janeway, C. A. J., Conrad, P. J., Lerner, E. A., Babich, J., Wettstein, P. and Murphy, D. B. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: possible role of T cell bound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132:662.
39. Oi, V. T., Jones, P. P., Goding, J. W. and Herzenberg, L. A. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr. Top. Microbiol. Immunol. 81:115.
40. Ward, E. S. 1992. Secretion of T cell receptor fragments from recombinant Escherichia coli cells. J. Mol. Biol. 224:885.
41. Kunkel, T. A., Roberts, J. D. and Zakour, R. A. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367.
42. Kabat E. A., Wu T. T., Perry H. M., Gottesman K. S. and Foeller C. 1991. Sequences of Proteins of Immunological Interest, vol. 1, 5th edn. US Department of Health and Human Services, Washington DC.
43. Meier, T., Arni, S., Malarkannan, S., Poincelet, M. and Hoessli, D. 1992. Immunodetection of biotinylated lymphocyte-surface proteins by enhanced chemiluminescence: a nonradioactive method for cell-surface protein analysis. Anal. Biochem. 204:220.
44. α domain of a TCR prevents the development of collagen-induced arthritis. J. Immunol. 155:4504.
45. Lipsky P. E. and Bottomly K. 1996. Measurement of human and murine interleukin 2 and interleukin 4. In Coligan J. E., ed., Current Protocols in Immunology, p. 6.3.1. John Wiley, New York.
46. Amit, A. G., Mariuzza, R. A., Phillips, S. E. V. and Poljak, R. J. 1986. Three-dimensional structure of an antigen-antibody complex at 2.8 Å Resolution. Science 233:747.
47. Acha-Orbea, H., Mitchell, D. J., Timmermann, L., Wraith, D. C., Tausch, G. S., Waldor, M. K., Zamvil, S. S., McDevitt, H. O. and Steinman, L. 1988. Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263.
48. Zamvil, S. S., Mitchell, D. J., Moore, A. C., Kitamura, K., Steinman, L. and Rothbard, J. B. 1986. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258.
49. Sette, A., Adorini, L., Colon, S. M., Buus, S. and Grey, H. M. 1989. Capacity of intact proteins to bind to MHC class II molecules. J. Immunol. 143:1265.
50. Lindner, R. and Unanue, E. R. 1996. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15:6910.
51. Jensen, P. E. 1993. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J. Immunol. 150:3347.
52. Deng, H., Apple, R., Clare-Salzler, M., Trembleau, S., Mathis, D., Adorini, L. and Sercarz, E. 1993. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J. Exp. Med. 178:1675.
53. Castellino, F., Zappacosta, F., Coligan, J. E. and Germain, R. N. 1998. Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J. Immunol. 161:4048.
54. Busch, R., Cloutier, I., Sekaly, R. P. and Hammerling, G. J. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J. 15:418.
55. Fairchild, P. J., Wildgoose, R., Atherton, E., Webb, S. and Wraith, D. C. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5:1151.
56. Wen, R., Cole, G. A., Surman, S., Blackman, M. A. and Woodland, D. L. 1996. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J. Exp. Med. 183:1083.
57. Thibodeau, J., Cloutier, I., Lavoie, P. M., Labrecque, N., Mourad, W., Jardetzky, T. and Sekaly, R. P. 1994. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science 266:1874.
58. von Bonin, A., Ehrlich, S., Malcherek, G. and Fleischer, B. 1995. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1. Eur J. Immunol. 25:2894.
59. Romagnoli, P. and Germain, R. N. 1994. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 180:1107.
60. Jardetzky, T. S., Brown, J. H., Gorga, J. C., Stern, L. J., Urban, R. G., Chi, Y. I., Stauffacher, C., Strominger, J. L. and Wiley, D. C. 1994. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711.
61. Matsui, K., Boniface, J. J., Reay, P. A., Schild, H., Fazekas de St Groth, B. and Davis, M. M. 1991. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788.
62. Weber, S., Traunecker, A., Oliveri, F., Gerhard, W. and Karjalainen, K. 1992. Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 356:793.
63. Corr, M., Slanetz, A. E., Boyd, L. F., Jelonek, M. T., Khilko, S., al-Ramadi, B. K., Kim, Y. S., Maher, S. E., Bothwell, A. L. and Margulies, D. H. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265:946.
64. Alam, S. M., Travers, P. J., Wung, J. L., Nasholds, W., Redpath, S., Jameson, S. C. and Gascoigne, N. R. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature 381:616.
65. Lyons, D. S., Lieberman, S. A., Hampl, J., Boniface, J. J., Chien, Y., Berg, L. J. and Davis, M. M. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53.
66. Hong, S. C., Chelouche, A., Lin, R. H., Shaywitz, D., Braunstein, N. S., Glimcher, L. and Janeway, C. A. J. 1992. An MHC interaction site maps to the amino-terminal half of the T cell receptor alpha chain variable domain. Cell 69:999.
67. Jorgensen, J. L., Esser, U., Fazekas de St Groth, B., Reay, P. A. and Davis, M. M. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224.
68. Brawley, J. V. and Concannon, P. 1996. Modulation of promiscuous T cell receptor recognition by mutagenesis of CDR2 residues. J. Exp. Med. 183:2043.
69. Wilson, N. A., Wolf, P., Ploegh, H., Ignatowicz, L., Kappler, J. and Marrack, P. 1998. Invariant chain can bind MHC class II at a site other than the peptide binding groove. J. Immunol. 161:4777.
70. Tompkins, S. M., Moore, J. C. and Jensen, P. E. 1996. An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med. 183:857.